Citation Impact
Citing Papers
The Mechanical Rigidity of the Extracellular Matrix Regulates the Structure, Motility, and Proliferation of Glioma Cells
2009
Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer
2015
KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
2008
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer
2007
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
2007
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Inference and analysis of cell-cell communication using CellChat
2021 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
2016
EGFR Antagonists in Cancer Treatment
2008 Standout
Acromegaly
2006 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
The Antitumoral Effects of Somatostatin Analog Therapy in Acromegaly
2005
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
A view on drug resistance in cancer
2019 StandoutNature
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Sexual dimorphism in cancer
2016
Global Cancer Statistics, 2002
2005 Standout
Host tissue determinants of tumour immunity
2019
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
2009
Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines
2009
Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease
2010
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
2007 StandoutNature
Stromal cells in tumor microenvironment and breast cancer
2012
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes
2012
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Development of 2A peptide-based strategies in the design of multicistronic vectors
2005
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
2018
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-α
2006
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Regulation of cancer cell metabolism
2011 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
2003
Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data
1997
Marking Embryonic Stem Cells with a 2A Self-Cleaving Peptide: A NKX2-5 Emerald GFP BAC Reporter
2008
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
2019
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Somatostatin Analog Therapy in Treatment of Gastrointestinal Disorders and Tumors
2003
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
The PI3K Pathway in Human Disease
2017 Standout
The role of TNF superfamily members in T-cell function and diseases
2009
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
Lessons from patient-derived xenografts for better in vitro modeling of human cancer
2014
Hypoxia signalling through mTOR and the unfolded protein response in cancer
2008
Cytokines in clinical cancer immunotherapy
2018
Epstein–Barr Virus Infection
2000 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
CD70 Signaling Is Critical for CD28-Independent CD8+ T Cell-Mediated Alloimmune Responses In Vivo
2005
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Obesity and Cancer Mechanisms: Cancer Metabolism
2016
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Infection of Primary Human Monocytes by Epstein-Barr Virus
2000
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Combining two strategies to improve perfusion and drug delivery in solid tumors
2013
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
2011
Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers
2016
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
2008 StandoutScienceNobel
Panitumumab, a Monoclonal Anti–Epidermal Growth Factor Receptor Antibody in Colorectal Cancer: Another One or the One?
2007
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features
2006
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo
2007 StandoutNobel
Immune targeting in breast cancer.
2015
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data
1997
Mechanistic Pathways of Sex Differences in Cardiovascular Disease
2016
CD8 T Cell-Intrinsic GITR Is Required for T Cell Clonal Expansion and Mouse Survival following Severe Influenza Infection
2010 StandoutNobel
Exploring the role of sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach
2016
Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.
2006
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
2017
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
2005 StandoutScience
Nonnuclear Actions of Estrogen
2002
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of Philippe Rochaix being referenced
Stromal Estrogen Receptor-α Promotes Tumor Growth by Normalizing an Increased Angiogenesis
2012
Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer
2011
Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors
2004
Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma
2005
Two antiestrogens affect differently chromatin remodeling of trefoil factor 1 (pS2) gene and the fate of estrogen receptor in MCF7 cells
2002
Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells
2010
Inhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts
2003
Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells
2013
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR
2005
Signal transduction of somatostatin receptors negatively controlling cell proliferation
2000
High endothelial venules (HEVs) in human melanoma lesions
2012
Increased expression of a COOH‐truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells
2002
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
2017
The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status
2000
Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
1993
Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies
2005
The AF-1 activation-function of ERα may be dispensable to mediate the effect of estradiol on endothelial NO production in mice
2002
High Endothelial Venule Blood Vessels for Tumor-Infiltrating Lymphocytes Are Associated with Lymphotoxin β–Producing Dendritic Cells in Human Breast Cancer
2013
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis
2002 Nobel
Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment?
2006
High incidence of Epstein–Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large‐cell lymphoma in children
1993
The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.
2003
Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238
2000 Nobel